Literature DB >> 18637071

Natural killer cells suppress full cycle HCV infection of human hepatocytes.

S-H Wang1, C-X Huang, L Ye, X Wang, L Song, Y-J Wang, H Liang, X-Y Huang, W-Z Ho.   

Abstract

The role of natural killer (NK) cells in controlling hepatitis C virus (HCV) infection and replication has not been fully delineated. We examined NK cell-mediated noncytolytic effect on full cycle HCV infection of human hepatocytes. Human hepatocytes (Huh7.5.1 cells) co-cultured with NK cells or treated with supernatants (SN) from NK cells cultures had significantly lower levels of HCV RNA and protein than control cells. This NK cell-mediated anti-HCV activity could be largely abolished by antibody to interferon-gamma (IFN-gamma). The investigation of the mechanisms for NK cell-mediated anti-HCV activity showed that NK SN-treated hepatocytes expressed higher levels of IFN-alpha/beta than the control cells. NK SN also enhanced IFN regulatory factor-3 and 7 expression in the hepatocytes. In addition, NK SN enhanced the expression of signal transducer and activator of transcription 1 and 2, the nuclear factors that are essential for the activation of IFN-mediated antiviral pathways. These data provide direct evidence at cellular and molecular levels that NK cells have a key role in suppressing HCV infection of and replication in human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637071      PMCID: PMC2675875          DOI: 10.1111/j.1365-2893.2008.01014.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  35 in total

Review 1.  Interferon activation and innate immunity.

Authors:  C Le Page; P Génin; M G Baines; J Hiscott
Journal:  Rev Immunogenet       Date:  2000

2.  Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection.

Authors:  K Yonekura; T Ichida; K Sato; S Yamagiwa; M Uchida; S Sugahara; S Ito; T Abo; H Asakura
Journal:  Liver       Date:  2000-10

Review 3.  Interferon signalling network in innate defence.

Authors:  Akinori Takaoka; Hideyuki Yanai
Journal:  Cell Microbiol       Date:  2006-06       Impact factor: 3.715

4.  Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C.

Authors:  U Düesberg; A M Schneiders; D Flieger; G Inchauspé; T Sauerbruch; U Spengler
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

5.  Real-time RT-PCR for quantitation of hepatitis C virus RNA.

Authors:  Ji Hong Yang; Jian Ping Lai; Steven D Douglas; David Metzger; Xian Hua Zhu; Wen Zhe Ho
Journal:  J Virol Methods       Date:  2002-04       Impact factor: 2.014

6.  Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C.

Authors:  M S Bonavita; A Franco; M Paroli; I Santilio; R Benvenuto; G De Petrillo; M Levrero; A Perrone; C Balsano; V Barnaba
Journal:  Int J Tissue React       Date:  1993

7.  Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.

Authors:  Michael Frese; Verena Schwärzle; Kerstin Barth; Nicole Krieger; Volker Lohmann; Sabine Mihm; Otto Haller; Ralf Bartenschlager
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Authors:  Stefania Crotta; Annalisa Stilla; Andreas Wack; Annalisa D'Andrea; Sandra Nuti; Ugo D'Oro; Marta Mosca; Franco Filliponi; R Maurizia Brunetto; Ferruccio Bonino; Sergio Abrignani; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

9.  Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.

Authors:  Chien-Te K Tseng; Gary R Klimpel
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma.

Authors:  N Kawarabayashi; S Seki; K Hatsuse; T Ohkawa; Y Koike; T Aihara; Y Habu; R Nakagawa; K Ami; H Hiraide; H Mochizuki
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

View more
  21 in total

1.  Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.

Authors:  Sung-Jae Park; Young S Hahn
Journal:  Rev Infect       Date:  2010-07-01

2.  Natural killer and natural killer T cells in liver fibrosis.

Authors:  Bin Gao; Svetlana Radaeva
Journal:  Biochim Biophys Acta       Date:  2012-09-26

3.  Different effects of the immunostimulatory drug Stimforte on infections of hepatitis C virus and herpes simplex virus type 1.

Authors:  D G Maldov; V L Andronova; S S Grigorian; E I Isaeva; P G Deryabin; D V Mishin; A A Balakina; A V Ilyichev; A A Terentyev; G A Galegov
Journal:  Dokl Biol Sci       Date:  2018-01-04

4.  Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.

Authors:  Qi Zhang; Rui Gong; Jing Qu; Yijing Zhou; Weiyong Liu; Mingzhou Chen; Yingle Liu; Ying Zhu; Jianguo Wu
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.

Authors:  Lucy Golden-Mason; Andrea L Cox; Jessica A Randall; Linling Cheng; Hugo R Rosen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 6.  STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver.

Authors:  Bin Gao; Hua Wang; Fouad Lafdil; Dechun Feng
Journal:  J Hepatol       Date:  2012-04-12       Impact factor: 25.083

7.  Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

Authors:  Kerstin A Stegmann; Niklas K Björkström; Sandra Ciesek; Sebastian Lunemann; Jerzy Jaroszewicz; Johannes Wiegand; Phillipp Malinski; Lynn B Dustin; Charles M Rice; Michael P Manns; Thomas Pietschmann; Markus Cornberg; Hans-Gustaf Ljunggren; Heiner Wedemeyer
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

8.  Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.

Authors:  Elisavet Serti; Heiyoung Park; Meghan Keane; Ashley C O'Keefe; Elenita Rivera; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gut       Date:  2016-01-04       Impact factor: 23.059

9.  Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.

Authors:  Pavel Bostik; Jaruda Kobkitjaroen; Weining Tang; Francois Villinger; Lara E Pereira; Dawn M Little; Susan T Stephenson; Mark Bouzyk; Aftab A Ansari
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 10.  Natural killer cells in liver disease.

Authors:  Zhigang Tian; Yongyan Chen; Bin Gao
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.